Form 4 for RYTM RHYTHM PHARMACEUTICALS, INC.
Accepted 2023-06-21 00:00:00 ET · period of report 2023-06-16 · accession 0001104659-23-073327 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-21 | 2023-06-16 | RYTM | Smith Hunter C | CFO | M - OptEx | $6.88 | +2,000 | 61.4K | +3% | +$13.8K |
| D | 2023-06-21 | 2023-06-16 | RYTM | Smith Hunter C | CFO | M - OptEx | $0.00 | -2,000 | 161.1K | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-16 | M | A | 2,000 | $6.88 | 61,406 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2023-06-16 | M | D | 2,000 | $0.00 | 161,094 | D | $6.88 · — to 2027-08-08 | 2,000 Common Stock | (F1) The stock options are fully vested. |